EUVIMEDEUVIMED entdecken
Crossref

Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer

Lucy Birtwistle, Sarah C. Brennan, Venessa Tsang, Matti L. Gild

Clinical Thyroidology® · 01.05.2026 · 38 (5) · 171-175

DOI: 10.1177/23299711261448628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 20.05.2026. Verfasst von Lucy Birtwistle und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Birtwistle, L., Brennan, S. C., Tsang, V., & Gild, M. L. (2026). Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer. Clinical Thyroidology®, 38(5), 171-175. https://doi.org/10.1177/23299711261448628

Vancouver

Birtwistle L, Brennan SC, Tsang V, Gild ML. Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer. Clinical Thyroidology®. 2026;38(5):171-175. doi:10.1177/23299711261448628

BibTeX
@article{Birtwistle2026,
  author = {Birtwistle, Lucy and Brennan, Sarah C. and Tsang, Venessa and Gild, Matti L.},
  title = {Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {5},
  pages = {171--175},
  doi = {10.1177/23299711261448628}
}
Kostenlos starten →